Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Limes Schlosskliniken AGXTER:LIK -0.94%93 EV-to-EBITDA is 11.47 as of Sep. 11, 2026, which is 22% below its 10-year median of 14.62. GuruFocus rates XTER:LIK with a GF Score™ of 93/100 and a GF Value™ of €530.12 (Fairly Valued). The stock has 2 warning signs investors should review. Among 518 Healthcare Providers & Services companies, Limes Schlosskliniken AG ranks worse than 55.02% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Limes Schlosskliniken AG's enterprise value is €155.48 Mil.
Limes Schlosskliniken AG's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was €13.56 Mil. Therefore, Limes Schlosskliniken AG's EV-to-EBITDA for today is 11.47.
The historical rank and industry rank for Limes Schlosskliniken AG's EV-to-EBITDA or its related term are showing as below:
XTER:LIK'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -261.95 Med: 14.62 Max: 113.4
Current: 11.47
During the past 9 years, the highest EV-to-EBITDA of Limes Schlosskliniken AG was 113.40. The lowest was -261.95. And the median was 14.62.
XTER:LIK's EV-to-EBITDA is ranked worse than 55.02% of 518
companies
in the Healthcare Providers & Services industry
Industry Median: 10.43
vs XTER:LIK: 11.47
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Limes Schlosskliniken AG (XTER:LIK) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Limes Schlosskliniken AG's PE Ratio (TTM) for today is calculated as:
Limes Schlosskliniken AG's share price for today is €525.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Limes Schlosskliniken AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was €18.300.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:LIK vs HCA, THC, EHC: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Limes Schlosskliniken AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Limes Schlosskliniken AG EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Limes Schlosskliniken AG's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Limes Schlosskliniken AG's EV-to-EBITDA falls into.
Limes Schlosskliniken AG's current Enterprise Value is €155.48 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Limes Schlosskliniken AG's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was €13.56 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Limes Schlosskliniken AG (XTER:LIK) has a EV-to-EBITDA of 11.47 as of Sep. 11, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Limes Schlosskliniken AG. This is 22% below median its historical median of 14.62. According to the industry distribution chart, Limes Schlosskliniken AG ranks #285 out of 518 companies in the Healthcare Providers & Services industry, placing it in the top 55%.
Is Limes Schlosskliniken AG's EV-to-EBITDA too high?
Limes Schlosskliniken AG's current EV-to-EBITDA of 11.47 is 22% below median its 10-year median of 14.62. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.43. Limes Schlosskliniken AG's value of 11.47 is 10% above this industry median. Based on the distribution chart, Limes Schlosskliniken AG ranks #285 out of 518 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Limes Schlosskliniken AG has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Limes Schlosskliniken AG's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Limes Schlosskliniken AG ranks #285 out of 518 companies for EV-to-EBITDA. This places Limes Schlosskliniken AG in the lower half of its industry. The industry median EV-to-EBITDA is 10.43. Limes Schlosskliniken AG's value of 11.47 is 10% above this benchmark. While the company's 10-year median is 14.62 vs. the industry median of 10.43, Limes Schlosskliniken AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.43, based on 518 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Limes Schlosskliniken AG's current EV-to-EBITDA of 11.47 is 10% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Limes Schlosskliniken AG. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Limes Schlosskliniken AG's current EV-to-EBITDA is 11.47, which is 22% below median its own 10-year median of 14.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Limes Schlosskliniken AG stock overvalued right now?
Based on GuruFocus' analysis, Limes Schlosskliniken AG (XTER:LIK) is currently considered Fairly Valued. The stock's GF Value™ is €530.12, compared to a current price of €525.00 — trading 1% below its estimated fair value. The current EV-to-EBITDA is 11.47, which is 22% below median its 10-year median of 14.62 and 10% above the Healthcare Providers & Services industry median of 10.43. Limes Schlosskliniken AG's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Limes Schlosskliniken AG (XTER:LIK), the current EV-to-EBITDA is 11.47 as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Limes Schlosskliniken AG (XTER:LIK) Overvalued in 2026?
Based on GuruFocus' analysis, Limes Schlosskliniken AG stock appears to be undervalued.
The current stock price of €525.00 is trading 1% below its estimated GF Value™ of €530.12.
GuruFocus considers Limes Schlosskliniken AG to be Fairly Valued.
Key valuation signals for XTER:LIK:
EV-to-EBITDA: 11.47 (22% below median its 10-year median of 14.62)
GF Value™: €530.12 vs. price of €525.00 (1% below fair value)
Industry Position: 10% above the Healthcare Providers & Services median (#285 of 518)
No single metric tells the full story. See the XTER:LIK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Limes Schlosskliniken AG operates mental and psychosomatic mental health clinic. It specializes in the treatment of stress disorders including depressions, Burnout Syndrome, Posttraumatic stress disorder, Anxiety / obsessive-compulsive disorder, eating disorders, personality disorders, and Somatization disorders such as chronic pain. LIMES Schlosskliniken operates in the market for high-quality private hospitals specializing in psychiatry, psychotherapy, and psychosomatics in Germany and Switzerland.
93GF Score
Get the complete analysis for XTER:LIK
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:LIK has been successfully added to your 
